Table 2.
Correlations between Ki-67 LI and Other Variables
| Clinicopathological variable /Category | Ki67<20% (n=6) | Ki67≥20% (n=44) | Total (100%) (n=50) | P value |
|---|---|---|---|---|
| Age | ||||
| ≤50 | 4 (13.3%) | 26 (86.7%) | 30 | 1 |
| >50 | 2 (10%) | 18 (90%) | 20 | |
| Menopausal status | ||||
| Post | 3 (10%) | 27 (90%) | 30 | 0.672 |
| Pre | 3 (15%) | 17 (85%) | 20 | |
| Family history | ||||
| Negative | 6 (13.6%) | 38 (86.4%) | 44 | 0.335 |
| Positive | 0 (0%) | 6 (100%) | 6 | |
| Tumor size | ||||
| ≤5 cm | 4 (9.1%) | 40 (90.9%) | 44 | 0.086 |
| >5 cm | 2 (33.3%) | 4 (66.7%) | 6 | |
| Lymph node positivity | ||||
| No | 2 (11.1%) | 16 (88.9%) | 18 | 1 |
| Yes | 4 (12.5%) | 28 (87.5%) | 32 | |
| Disease stage | ||||
| I &II | 3 (9.1%) | 30 (90.9%) | 33 | 0.378 |
| III | 3 (17.6%) | 14 (82.4%) | 17 | |
| Tumor grade | ||||
| GI&GII | 4 (12.1%) | 29 (87.9%) | 33 | 1 |
| GIII | 2 (11.8%) | 15 (88.2%) | 17 | |
| TOP2A gene status | ||||
| Normal | 6 (14.6%) | 35 (85.4%) | 41 | 0.576 |
| TOP2A gene status | ||||
| Abnormal | 0 (0%) | 9 (100%) | 9 | |
| Amplified | 0 (0%) | 5 (100%) | 5 | 0.511 |
| Deleted | 0 (0%) | 4 (100%) | 4 | |
| Normal | 6 (14.6%) | 35 (85.4%) | 41 | |
| Chromosome 17 CEP status | ||||
| Normal | 6 (14%) | 37 (86%) | 43 | 0.292 |
| Polysomy | 0 (0%) | 7 (100%) | 7 | |
| Disease outcome | ||||
| Good | 5 (12.8%) | 34 (87.2%) | 39 | 1 |
| Poor | 1 (9.1%) | 10 (90.9%) | 11 | |